Literature DB >> 16267232

Neuronal L-type calcium channels open quickly and are inhibited slowly.

Thomas D Helton1, Weifeng Xu, Diane Lipscombe.   

Abstract

Neuronal L-type calcium channels are essential for regulating activity-dependent gene expression, but they are thought to open too slowly to contribute to action potential-dependent calcium entry. A complication of studying native L-type channels is that they represent a minor fraction of the whole-cell calcium current in most neurons. Dihydropyridine antagonists are therefore widely used to establish the contribution of L-type channels to various neuronal processes and to study their underlying biophysical properties. The effectiveness of these antagonists on L-type channels, however, varies with stimulus and channel subtype. Here, we study recombinant neuronal L-type calcium channels, CaV1.2 and CaV1.3. We show that these channels open with fast kinetics and carry substantial calcium entry in response to individual action potential waveforms, contrary to most studies of native L-type currents. Neuronal CaV1.3 L-type channels were as efficient as CaV2.2 N-type channels at supporting calcium entry during action potential-like stimuli. We conclude that the apparent slow activation of native L-type currents and their lack of contribution to single action potentials reflect the state-dependent nature of the dihydropyridine antagonists used to study them, not the underlying properties of L-type channels.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16267232      PMCID: PMC6725800          DOI: 10.1523/JNEUROSCI.1089-05.2005

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  85 in total

1.  The dynamics of somatic input processing in spinal motoneurons in vivo.

Authors:  Cassie S Mitchell; Robert H Lee
Journal:  J Neurophysiol       Date:  2010-12-29       Impact factor: 2.714

2.  Dopamine Inhibition Differentially Controls Excitability of Substantia Nigra Dopamine Neuron Subpopulations through T-Type Calcium Channels.

Authors:  Rebekah C Evans; Manhua Zhu; Zayd M Khaliq
Journal:  J Neurosci       Date:  2017-03-06       Impact factor: 6.167

3.  Multiple modes of amplification of synaptic inhibition to motoneurons by persistent inward currents.

Authors:  Tuan V Bui; Giovanbattista Grande; P Ken Rose
Journal:  J Neurophysiol       Date:  2007-11-28       Impact factor: 2.714

4.  Electrical coupling between the human serotonin transporter and voltage-gated Ca(2+) channels.

Authors:  Iwona Ruchala; Vanessa Cabra; Ernesto Solis; Richard A Glennon; Louis J De Felice; Jose M Eltit
Journal:  Cell Calcium       Date:  2014-04-27       Impact factor: 6.817

Review 5.  Calcium signalling through L-type calcium channels: role in pathophysiology of spinal nociceptive transmission.

Authors:  Olivier Roca-Lapirot; Houda Radwani; Franck Aby; Frédéric Nagy; Marc Landry; Pascal Fossat
Journal:  Br J Pharmacol       Date:  2017-03-24       Impact factor: 8.739

6.  L-type voltage-gated calcium channels in conditioned fear: a genetic and pharmacological analysis.

Authors:  Brandon C McKinney; Wilson Sze; Jessica A White; Geoffrey G Murphy
Journal:  Learn Mem       Date:  2008-04-25       Impact factor: 2.460

7.  Cav1.3 channel voltage dependence, not Ca2+ selectivity, drives pacemaker activity and amplifies bursts in nigral dopamine neurons.

Authors:  Ilva Putzier; Paul H M Kullmann; John P Horn; Edwin S Levitan
Journal:  J Neurosci       Date:  2009-12-09       Impact factor: 6.167

8.  Amyloid precursor protein regulates Cav1.2 L-type calcium channel levels and function to influence GABAergic short-term plasticity.

Authors:  Li Yang; Zilai Wang; Baiping Wang; Nicholas J Justice; Hui Zheng
Journal:  J Neurosci       Date:  2009-12-16       Impact factor: 6.167

9.  Deletion of the L-type calcium channel Ca(V) 1.3 but not Ca(V) 1.2 results in a diminished sAHP in mouse CA1 pyramidal neurons.

Authors:  Amy E Gamelli; Brandon C McKinney; Jessica A White; Geoffrey G Murphy
Journal:  Hippocampus       Date:  2011-02       Impact factor: 3.899

Review 10.  Target- and mechanism-based therapeutics for neurodegenerative diseases: strength in numbers.

Authors:  Paul C Trippier; Kristin Jansen Labby; Dustin D Hawker; Jan J Mataka; Richard B Silverman
Journal:  J Med Chem       Date:  2013-03-27       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.